Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when ImmunityBio, Inc. publishes a filing, an earnings call transcript or a press release.

Get IBRX alerts

About Linda Maxwell

Linda Maxwell is recorded as Board Member at ImmunityBio, Inc. (IBRX) and Board Member at UNITED THERAPEUTICS Corp (UTHR). The newest filing on record that lists Linda Maxwell as Board Member at ImmunityBio, Inc. (IBRX) is dated April 30, 2026. The newest filing on record that lists Linda Maxwell as Board Member at UNITED THERAPEUTICS Corp (UTHR) is dated April 29, 2022. UNITED THERAPEUTICS Corp reported in an 8-K filed June 29, 2026 that Linda Maxwell was appointed Director, effective June 26, 2026. UNITED THERAPEUTICS Corp reported in an 8-K filed June 27, 2025 that Linda Maxwell was appointed director, effective June 26, 2025. UNITED THERAPEUTICS Corp reported in an 8-K filed June 28, 2023 that Linda Maxwell was appointed Director, effective June 26, 2023. ImmunityBio, Inc. is classified in the Biotechnology industry within the Healthcare sector. UNITED THERAPEUTICS Corp is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at ImmunityBio, Inc. includes Richard Adcock (CEO and Board Member), Patrick Soon-Shiong (Chairman and Board Member), David Sachs (CFO and Chief Accounting Officer) and 7 others.

“Election of directors, each to serve a term of one year: Nominee Votes For ... Linda Maxwell 35,472,607 725,977 20,293 1,194,857”
UNITED THERAPEUTICS Corp Form 8-K, filed June 29, 2026 · Read the filing
“On June 26, 2025, the Company held its 2025 Annual Meeting of Shareholders.”
UNITED THERAPEUTICS Corp Form 8-K, filed June 27, 2025 · Read the filing

Affiliation history

Company network

Leadership on record at ImmunityBio, Inc.

Leadership on record at UNITED THERAPEUTICS Corp

Recent activity